Fabrazyme (beta-agalsidase) 35mg
Agalsidase beta has a place with the gathering of drugs known as catalyst substitution treatment. It is utilized as chemical supplanting treatment for individuals with Fabry sickness, which is a hereditary issue where the dimensions of alpha-galactosidase (a catalyst that separates fats) is low or missing. With Fabry malady, globotriaosylceramide (or GL-3; a fat substance) isn’t expelled from cells in the body and begins to aggregate in the dividers of veins and organs. By lessening GL-3 levels in the body, agalsidase beta moderates the rate of movement of Fabry illness in the kidney, heart, and mind.
The usual dose of agalsidase beta is 1 mg per kilogram of body weight given every 2 weeks as an infusion into a vein.
Many things can affect the dose of medication that a person needs, such as body weight, other medical conditions, and other medications. If your doctor has recommended a dose different from the ones listed here,do not change the way that you are using the medication without consulting your doctor.
It is important this medication be given exactly as recommended by your doctor. If you miss an appointment to receive agalsidase beta, contact your doctor as soon as possible to reschedule your appointment. If you are receiving this medication at home and miss a dose, contact your doctor.
Vials of this medication are stored in the refrigerator. After prepared for an infusion, this medication should be used immediately.
Do not dispose of medications in wastewater (e.g. down the sink or in the toilet) or in household garbage. Ask your pharmacist how to dispose of medications that are no longer needed or have expired.
- back pain
- decreased hearing
- difficulty sleeping
- pain, including muscle and neck pain
- ringing in the ears
- skin rash
- stomach discomfort
- symptoms of an infection (cough, runny nose, sore throat)